TET2 and colorectal carcinoma: In conclusion, our study demonstrates that TET1, TET2, and TET3 transcript levels in cancerous tissues are reduced and provide the first evidence that TET2 mRNA in histopathologically unchanged tissue from CRC patients may be an independent predictor of relapse and OS.